AbbVie Inc

Introduction
AbbVie Inc. is a global biopharmaceutical company headquartered in North Chicago, Illinois. Established in 2013 as a spin-off from Abbott Laboratories, AbbVie has rapidly become one of the largest pharmaceutical companies in the world. It is widely recognized for its portfolio in immunology, oncology, neuroscience, eye care, and aesthetics. AbbVie’s blockbuster drug Humira has been one of the world’s top-selling medicines for years, driving significant growth and expansion.

Mission and Vision

Mission: To discover and deliver innovative medicines and solutions that address serious health issues and enhance people’s lives.
Vision: To be a world-class biopharmaceutical leader that transforms healthcare through science, innovation, and patient-focused care.

Products and Services

Immunology: Humira, Rinvoq, Skyrizi – treatments for autoimmune conditions such as rheumatoid arthritis, psoriasis, and Crohn’s disease.
Oncology: Imbruvica, Venclexta – therapies for blood cancers and solid tumors.
Neuroscience: Treatments for depression, migraine, and neurological disorders, including Botox Therapeutics.
Eye Care: Products under Allergan (acquired in 2020), including Restasis.
Aesthetics: Botox Cosmetic, Juvederm fillers, and other aesthetic medicine solutions.
Virology & Other Therapies: HIV treatments and other specialty medicines.

Growth and Innovation
AbbVie has expanded aggressively through acquisitions, most notably the $63 billion acquisition of Allergan in 2020, which diversified its portfolio into eye care and aesthetics. The company is heavily invested in immunology, oncology, and neuroscience, with a strong pipeline of biologics and targeted therapies. AbbVie is transitioning beyond Humira with newer immunology drugs like Rinvoq and Skyrizi driving future growth.

Global Impact
With operations in more than 75 countries, AbbVie medicines reach patients worldwide. Its therapies in immunology and oncology have improved millions of lives, while its aesthetics division has made AbbVie a leader in cosmetic medicine. AbbVie also engages in global health partnerships, access initiatives, and sustainability programs to reduce its environmental footprint and expand patient access.